Hormone Receptor-positive Metastatic Breast Cancer

• CLINICAL_TRIALS research · 2025-08-12
  Clinical Trial Update: Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC [Phase 2]

  Phase 2 clinical trial update examining determinants of resistance to endocrine therapy and the effect of a CDK4/6 inhibitor in hormone rece…

• CLINICAL_TRIALS research · 2025-05-16
  Clinical Trial Update: Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management [Phase 4]

  This document describes a Phase 4 clinical trial evaluating the combination of abemaciclib with endocrine therapy for hormone receptor-posit…

• CLINICAL_TRIALS research · 2025-03-25
  Clinical Trial Update: Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors [Phase 1, Phase 2]

  Phase 1/2 study of Sacituzumab Govitecan in Japanese participants with advanced solid tumors is ongoing, including metastatic triple-negativ…

• CLINICAL_TRIALS research · 2015-12-29
  Clinical Trial Update: Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer

  This entry reports the completion of a Danish observational study evaluating everolimus plus exemestane in HR-positive, HER2-negative metast…